Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2006

Open Access 01-12-2006 | Research

Randomization in substance abuse clinical trials

Authors: Sarra L Hedden, Robert F Woolson, Robert J Malcolm

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2006

Login to get access

Abstract

Background

A well designed randomized clinical trial rates as the highest level of evidence for a particular intervention's efficacy. Randomization, a fundamental feature of clinical trials design, is a process invoking the use of probability to assign treatment interventions to patients. In general, randomization techniques pursue the goal of providing objectivity to the assignment of treatments, while at the same time balancing for treatment assignment totals and covariate distributions. Numerous randomization techniques, each with varying properties of randomness and balance, are suggested in the statistical literature. This paper reviews common randomization techniques often used in substance abuse research and an application from a National Institute on Drug Abuse (NIDA)-funded clinical trial in substance abuse is used to illustrate several choices an investigator faces when designing a clinical trial.

Results

Comparisons and contrasts of randomization schemes are provided with respect to deterministic and balancing properties. Specifically, Monte Carlo simulation is used to explore the balancing nature of randomization techniques for moderately sized clinical trials. Results demonstrate large treatment imbalance for complete randomization with less imbalance for the urn or adaptive scheme. The urn and adaptive randomization methods display smaller treatment imbalance as demonstrated by the low variability of treatment allocation imbalance. For all randomization schemes, covariate imbalance between treatment arms was small with little variation between adaptive schemes, stratified schemes and unstratified schemes given that sample sizes were moderate to large.

Conclusion

We develop this paper with the goal of reminding substance abuse researchers of the broad array of randomization options available for clinical trial designs. There may be too quick a tendency for substance abuse researchers to implement the fashionable urn randomization schemes and other highly adaptive designs. In many instances, simple or blocked randomization with stratification on a major covariate or two will accomplish the same objectives as an urn or adaptive design, and it can do so with more simply implemented schedules and without the dangers of overmatching. Furthermore, the proper analysis, fully accounting for the stratified design, can be conducted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anthony W, Rogers ES, Farkas M: Research on evidence-based practices: future directions in an era of recovery. Community Mental Health Journal. 2003, 39: 101-114. 10.1023/A:1022601619482.CrossRefPubMed Anthony W, Rogers ES, Farkas M: Research on evidence-based practices: future directions in an era of recovery. Community Mental Health Journal. 2003, 39: 101-114. 10.1023/A:1022601619482.CrossRefPubMed
2.
go back to reference Sackett DL, Strauss SE, Richardson WS, Orsenberg W, Haynes RB: Evidence Base Medicine. 2000, London, Churchill Livingstone Sackett DL, Strauss SE, Richardson WS, Orsenberg W, Haynes RB: Evidence Base Medicine. 2000, London, Churchill Livingstone
3.
go back to reference Lachin JM: Properties of simple randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 312-326. 10.1016/0197-2456(88)90046-3.CrossRefPubMed Lachin JM: Properties of simple randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 312-326. 10.1016/0197-2456(88)90046-3.CrossRefPubMed
4.
go back to reference Stout RL, Wirtz PW, Carbonari JP, Del Boca FK: Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal of Studies on Alcohol. 1996, 70-75. Suppl 12 Stout RL, Wirtz PW, Carbonari JP, Del Boca FK: Ensuring balanced distribution of prognostic factors in treatment outcome research. Journal of Studies on Alcohol. 1996, 70-75. Suppl 12
5.
go back to reference Muller MJ, Scheurich A, Wetzel H, Szegedi A, Hautzinger M: Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research. Alcohol & Alcoholism. 2005, 40: 124-131. 10.1093/alcalc/agh131.CrossRef Muller MJ, Scheurich A, Wetzel H, Szegedi A, Hautzinger M: Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research. Alcohol & Alcoholism. 2005, 40: 124-131. 10.1093/alcalc/agh131.CrossRef
6.
go back to reference Ludbrook JD, Dudley H: Why permutation tests are superior to t and f tests in biomedical research. The American Statistician. 1998, 52: 127-132. Ludbrook JD, Dudley H: Why permutation tests are superior to t and f tests in biomedical research. The American Statistician. 1998, 52: 127-132.
7.
go back to reference Lachin JM, Matts JP, Wei LJ: Randomization in clinical trials: conclusions and recommendations. Controlled Clinical Trials. 1988, 9: 365-374. 10.1016/0197-2456(88)90049-9.CrossRefPubMed Lachin JM, Matts JP, Wei LJ: Randomization in clinical trials: conclusions and recommendations. Controlled Clinical Trials. 1988, 9: 365-374. 10.1016/0197-2456(88)90049-9.CrossRefPubMed
8.
go back to reference Smythe R, Wei LJ: Significance tests with restricted randomization design. Biometrika. 1983, 70: 496-500.CrossRef Smythe R, Wei LJ: Significance tests with restricted randomization design. Biometrika. 1983, 70: 496-500.CrossRef
9.
go back to reference Kalish LA, Begg CB: Treatment allocation methods in clinical trials: a review. Statistics in Medicine. 1985, 4: 129-144.CrossRefPubMed Kalish LA, Begg CB: Treatment allocation methods in clinical trials: a review. Statistics in Medicine. 1985, 4: 129-144.CrossRefPubMed
10.
11.
go back to reference Matts JP, McHugh RB: Analysis of Accrual Randomized Clinical Trials with Balanced Groups in Strata. Journal of Chronic Disease. 1978, 31: 725-740. 10.1016/0021-9681(78)90057-7.CrossRef Matts JP, McHugh RB: Analysis of Accrual Randomized Clinical Trials with Balanced Groups in Strata. Journal of Chronic Disease. 1978, 31: 725-740. 10.1016/0021-9681(78)90057-7.CrossRef
12.
go back to reference Efron B: Forcing a Sequential Experiment to Be Balanced. Biometrika. 1971, 58: 403-17.CrossRef Efron B: Forcing a Sequential Experiment to Be Balanced. Biometrika. 1971, 58: 403-17.CrossRef
13.
go back to reference Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI: Stratified randomization for clinical trials. Journal of Clinical Epidemiology. 1999, 52: 19-26. 10.1016/S0895-4356(98)00138-3.CrossRefPubMed Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI: Stratified randomization for clinical trials. Journal of Clinical Epidemiology. 1999, 52: 19-26. 10.1016/S0895-4356(98)00138-3.CrossRefPubMed
14.
go back to reference Feinstein AR, Landis JR: The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. Journal of Chronic Diseases. 1976, 29: 277-284. 10.1016/0021-9681(76)90080-1.CrossRefPubMed Feinstein AR, Landis JR: The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. Journal of Chronic Diseases. 1976, 29: 277-284. 10.1016/0021-9681(76)90080-1.CrossRefPubMed
15.
go back to reference Green SB, Byar DP: The effect of stratified randomization on size and power of statistical tests in clinical trials. Journal of Chronic Disease. 1978, 31: 445-454. 10.1016/0021-9681(78)90008-5.CrossRef Green SB, Byar DP: The effect of stratified randomization on size and power of statistical tests in clinical trials. Journal of Chronic Disease. 1978, 31: 445-454. 10.1016/0021-9681(78)90008-5.CrossRef
16.
go back to reference Rosenberger WF, Lachin JM: Randomization in Clinical Trials: Theory and Practice. 2002, New York: John Wiley & SonsCrossRef Rosenberger WF, Lachin JM: Randomization in Clinical Trials: Theory and Practice. 2002, New York: John Wiley & SonsCrossRef
17.
go back to reference Matts JP, Lachin JM: Properties of permuted-block randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 327-344. 10.1016/0197-2456(88)90047-5.CrossRefPubMed Matts JP, Lachin JM: Properties of permuted-block randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 327-344. 10.1016/0197-2456(88)90047-5.CrossRefPubMed
18.
go back to reference Hallstrom A, Davis K: Imbalance in treatment assignments in stratified blocked randomization. Controlled Clinical Trials. 1988, 9: 375-382. 10.1016/0197-2456(88)90050-5.CrossRefPubMed Hallstrom A, Davis K: Imbalance in treatment assignments in stratified blocked randomization. Controlled Clinical Trials. 1988, 9: 375-382. 10.1016/0197-2456(88)90050-5.CrossRefPubMed
19.
go back to reference Wei LJ: Exact two sample permutation tests based on the randomized play the winner rule. Biometrika. 1988, 5: 603-606.CrossRef Wei LJ: Exact two sample permutation tests based on the randomized play the winner rule. Biometrika. 1988, 5: 603-606.CrossRef
20.
go back to reference Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometric. 1975, 31: 103-115.CrossRef Pocock SJ, Simon R: Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometric. 1975, 31: 103-115.CrossRef
21.
go back to reference Taves DR: Minimization: a new method of assigning patients to treatment and control groups. Clinical Pharmacology & Therapeutics. 1974, 15: 443-453. Taves DR: Minimization: a new method of assigning patients to treatment and control groups. Clinical Pharmacology & Therapeutics. 1974, 15: 443-453.
22.
go back to reference Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, Weinrieb RM, O'Brien CP: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors. 2002, 27: 251-260. 10.1016/S0306-4603(01)00171-X.CrossRefPubMed Kampman KM, Volpicelli JR, Mulvaney F, Rukstalis M, Alterman AI, Pettinati H, Weinrieb RM, O'Brien CP: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors. 2002, 27: 251-260. 10.1016/S0306-4603(01)00171-X.CrossRefPubMed
23.
go back to reference Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P: Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American Journal of Drug & Alcohol Abuse. 2004, 30: 749-764. 10.1081/ADA-200037538.CrossRef Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P: Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. American Journal of Drug & Alcohol Abuse. 2004, 30: 749-764. 10.1081/ADA-200037538.CrossRef
24.
go back to reference Jones EM, Knutson D, Haines D: Common problems in patients recovering from chemical dependency. American Family Physician. 1971, 68: 71-78. Jones EM, Knutson D, Haines D: Common problems in patients recovering from chemical dependency. American Family Physician. 1971, 68: 71-78.
25.
go back to reference Levin FR, Evans SM, McDowell DM, Kleber HD: Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry. 1988, 59: 300-305.CrossRef Levin FR, Evans SM, McDowell DM, Kleber HD: Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry. 1988, 59: 300-305.CrossRef
26.
go back to reference Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C: Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug & Alcohol Dependence. 1977, 44: 35-40. 10.1016/S0376-8716(96)01319-1.CrossRef Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C: Gender differences in cocaine dependent patients: a 6 month follow-up study. Drug & Alcohol Dependence. 1977, 44: 35-40. 10.1016/S0376-8716(96)01319-1.CrossRef
27.
go back to reference Kampman KM, Pettinati HM, Volpicelli JR, Oslin DM, Lipkin C, Sparkman T, O'Brien CP: Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. American Journal on Addictions. 2004, 13: 74-82. 10.1080/10550490490265389.CrossRefPubMed Kampman KM, Pettinati HM, Volpicelli JR, Oslin DM, Lipkin C, Sparkman T, O'Brien CP: Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. American Journal on Addictions. 2004, 13: 74-82. 10.1080/10550490490265389.CrossRefPubMed
28.
29.
go back to reference Zhao W: Study on the Statistical Properties of Randomization in Clinical Trials. Unpublished doctoral dissertation. 1999, Medical University of South Carolina, Department of Biostatistics, Bioinformatics and Epdemiology Zhao W: Study on the Statistical Properties of Randomization in Clinical Trials. Unpublished doctoral dissertation. 1999, Medical University of South Carolina, Department of Biostatistics, Bioinformatics and Epdemiology
30.
go back to reference Weir CJ, Lees KR: Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Statistics in Medicine. 2003, 22: 705-726. 10.1002/sim.1366.CrossRefPubMed Weir CJ, Lees KR: Comparison of stratification and adaptive methods for treatment allocation in an acute stroke clinical trial. Statistics in Medicine. 2003, 22: 705-726. 10.1002/sim.1366.CrossRefPubMed
31.
go back to reference Wei LJ, Lachin JM: Properties of the urn randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 345-364. 10.1016/0197-2456(88)90048-7.CrossRefPubMed Wei LJ, Lachin JM: Properties of the urn randomization in clinical trials. Controlled Clinical Trials. 1988, 9: 345-364. 10.1016/0197-2456(88)90048-7.CrossRefPubMed
32.
go back to reference Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillion PW, Zwischenberger JB: Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985, 76: 479-487.PubMed Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillion PW, Zwischenberger JB: Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985, 76: 479-487.PubMed
33.
go back to reference Zelen M: Play-the-winner rule and the controlled clinical trial. Journal of the American Statistical Association. 1969, 64: 131-146.CrossRef Zelen M: Play-the-winner rule and the controlled clinical trial. Journal of the American Statistical Association. 1969, 64: 131-146.CrossRef
34.
go back to reference Scott NW, McPherson GC, Ramsay CR, Campbell MK: The method of minimization for allocation to clinical trials. a review. Controlled Clinical Trials. 2002, 23: 662-674. 10.1016/S0197-2456(02)00242-8.CrossRefPubMed Scott NW, McPherson GC, Ramsay CR, Campbell MK: The method of minimization for allocation to clinical trials. a review. Controlled Clinical Trials. 2002, 23: 662-674. 10.1016/S0197-2456(02)00242-8.CrossRefPubMed
35.
go back to reference Halpern J, Brown BW: Sequential treatment allocation procedures in clinical trials – with particular attention to the analysis of results for the biased coin design. Statistics in Medicine. 1986, 5: 211-229.CrossRefPubMed Halpern J, Brown BW: Sequential treatment allocation procedures in clinical trials – with particular attention to the analysis of results for the biased coin design. Statistics in Medicine. 1986, 5: 211-229.CrossRefPubMed
36.
go back to reference Kalish LA, Begg CB: The Impact of Treatment Allocation Procedures on Nominal Significance Levels and Bias. Controlled Clinical Trial. 1987, 8: 121-135. 10.1016/0197-2456(87)90037-7.CrossRef Kalish LA, Begg CB: The Impact of Treatment Allocation Procedures on Nominal Significance Levels and Bias. Controlled Clinical Trial. 1987, 8: 121-135. 10.1016/0197-2456(87)90037-7.CrossRef
37.
go back to reference Freedman LS, White SJ: On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics. 1976, 32: 691-694.CrossRefPubMed Freedman LS, White SJ: On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics. 1976, 32: 691-694.CrossRefPubMed
Metadata
Title
Randomization in substance abuse clinical trials
Authors
Sarra L Hedden
Robert F Woolson
Robert J Malcolm
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2006
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/1747-597X-1-6

Other articles of this Issue 1/2006

Substance Abuse Treatment, Prevention, and Policy 1/2006 Go to the issue